From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Gastroenterology>
  4. Summary and Comment

Acid Symptoms After Proton-Pump–Inhibitor Discontinuation

Healthy volunteers developed acid-related symptoms after discontinuing a PPI that they had taken for 8 weeks.

Proton-pump inhibitors (PPIs) block the secretion of gastric acid from parietal cells. As a result, serum gastrin levels rise and parietal-cell mass increases. When PPI therapy is discontinued, acid production rebounds.

To clarify the clinical significance of this rebound, investigators in Denmark randomized 120 healthy volunteers without gastrointestinal symptoms to receive either 12 weeks of placebo (control group) or 8 weeks of esomeprazole (40 mg/day) followed by 4 weeks of placebo (PPI group). Each week, participants completed the Gastrointestinal Symptom Rating Scale (GSRS) survey.

The two groups had similar baseline GSRS scores. At weeks 10, 11, and 12, the mean scores on acid-related symptoms were significantly higher in the PPI group than in the control group, and the gap between the groups widened during the course of these 3 weeks. Significantly more PPI recipients than controls (44% vs. 15%) reported heartburn, acid regurgitation, or dyspepsia during at least 1 week from weeks 9 through 12.

Comment: The data from this well-designed study suggest that discontinuation of PPI therapy results in acid-related symptoms. The findings must be confirmed in other populations, but they nonetheless have important implications, given the large number of patients without clear indications for PPI therapy who receive it long term. If a patient who does not truly need a PPI reports transient acid-related symptoms when the drug is discontinued, the treating clinician might conclude that the patient has underlying acid-related disease and resume PPI therapy unnecessarily. Future studies also ought to follow patients for longer periods to document how long post-PPI acid-related symptoms persist and, thereby, guide clinical decisions about whether to resume PPI therapy.

David J. Bjorkman, MD, MSPH (HSA), SM (Epid.)

Published in Journal Watch Gastroenterology September 11, 2009

Citation(s):

Reimer C et al. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009 Jul; 137:80. (http://dx.doi.org/10.1053/j.gastro.2009.03.058)

Reader Remarks:

Read all Reader Remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

(more...)

Related Content

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.